Age-related macular degeneration (AMD) is one of the leading causes of vision loss in people over 50 across industrialized countries…

Givaudan, The Vernier-based (Canton of Geneva) global leader in Fragrance & Beauty, announced that it has reached an agreement to…

NETRIS Pharma, a clinical-stage oncology company with roots in Lyon since 2008 and a Geneva presence since 2016, has announced…

TheraPPI, a preclinical biotech company operating both in Lyon (France) and Geneva (Switzerland), announced the second closing of its Pre-Seed financing….

Isomorphic Labs, the Google DeepMind spin-off on a mission to “solve all disease” with artificial intelligence, has secured $2.1 billion…

The Vaud-based company, which specializes in neuro-ophthalmology and ophthalmology, stated that the primary endpoint of the DIAMOND trials was not…

The Vaud-based foodtech startup TUUS has obtained CHF 150,000 from Venture Kick to advance a plant-based hydrogel platform for the…

ABILITY Neurotech, a Geneva-based clinical-stage brain-computer interface company, announced it has received Investigational Medical Device Dossier (IMDD) approval from the…

Eli Lilly, the American pharmaceutical giant with a Swiss presence through its branch in Vernier, in the canton of Geneva,…

MindMaze Therapeutics Holding SA, a Lausanne-based global leader in scalable precision neurotherapeutics, announces it has entered into a definitive agreement…

Asinov School — School of Embodied Intelligence — will open its doors in September 2026 in Renens, within UniverCité/Station R…

Tucked away in Vouvry, in the Swiss canton of Valais, TRB Chemedica is the kind of company that rarely makes…